Completely revised and updated, the second edition of the extremely successful Brain Tumors incorporates current conceptual, technical and practical advances in the field. It includes significant technical advances in the diagnosis, classification and analysis of brain tumors, advances in the surgical and radiotherapeutic management of many types of brain tumors, and advances in chemotherapy, immunotherapy and biological therapies. The book is both clinically focused and very accessible, making it very popular with busy clinicians tackling difficult problems.
"synopsis" may belong to another edition of this title.
Edward R. Laws is currently the Director of the Pituitary/Neuroendocrine Center at Brigham and Women’s Hospital in Boston and Professor of Surgery at Harvard Medical School. He was formerly the President of the American College of Surgeons and has served as President of the World Federation of Neurosurgical Societies, President of the Congress of Neurological Surgeons, Editor of Neurosurgery, Chairman of the Board of Trustees of the Foundation for International Education in Neurosurgery, Director of the American Board of Neurological Surgery, President of the American Association of Neurological Surgeons, and President of the Pituitary Society.
Reductionism is, in the words of Peter Medawar, ``the most successful research stratagem ever devised.'' Thanks to reductive analysis, biomedical research has produced countless pieces of information. What we need from time to time is a fresh selection of relevant results. A textbook that attempts an integration of recent advances is indispensable, particularly in the study of cerebral tumors, in which developments in diagnosis and therapy are abundant.
Neuro-oncology is a challenging discipline. As compared with neoplasms in other organs, brain tumors have several peculiarities. The cause remains elusive, the clinical manifestations are diverse, and therapy continues to be mainly surgical. In the case of malignant brain tumors, perhaps more than in all other forms of cancer, a paradox has become evident: our diagnostic capabilities have become more and more precise, but there have been few advances in treatment during the past 50 years.
The fact that a second edition of Brain Tumors has appeared six years after the first is evidence of rapid advances in all areas of neuro-oncology. The book will be indispensable for anyone involved in the study of brain tumors, especially for neuropathologists, neurologists, neurosurgeons, endocrinologists, and radiologists. The editors have gathered well-known experts to author each of the 63 chapters, providing the reader with a comprehensive selection of important issues on all aspects of brain tumors and ensuring that this book will become a classic source of multidisciplinary information.
The organization of the book is didactic; section I comprises 23 chapters that explore all basic diagnostic and therapeutic aspects of neuro-oncology; section II includes a thorough review of each type of tumor, from gliomas to metastases. Each chapter discusses epidemiology, histopathology, clinical data, diagnosis, and therapeutic procedures. In all, there are more than 1000 pages of nonrepetitive information.
The book is particularly useful as a first source of integrated information for the everyday practice of neuro-oncology. I particularly enjoyed the chapters on historical perspective, the developing brain and cellular targets for neoplastic transformation, epidemiology and prognosis, experimental therapy for brain tumors, and laboratory-model systems for brain-tumor research. All of these chapters, and many others, formulate interesting concepts and contain countless pieces of important information on the biology of brain tumors. Nonetheless, the word ``encyclopedic'' is a risky editorial compromise for ``completeness,'' and I think that some important pieces are missing from the book. For instance, although malignant gliomas are by far the most frequent primary brain tumors, only 25 pages of text are devoted to them. The pros and cons of aggressive versus conservative therapy for malignant gliomas should have been more thoroughly discussed, especially with regard to cases that predictably will not benefit from aggressive therapy.
I envision that tumor genetics, immunotherapy, radiosurgery, and technologic advances in instrumentation, robotics, and cybernetics will revolutionize our approach to brain tumors. The field of radiosurgery is rapidly moving toward the development of sophisticated equipment and precise three-dimensional imaging software that will enable the neurosurgeon to function in a virtual scenario, which will prevent the usual complications of open surgery. In the future, the neurosurgeon will be an expert on cybernetics, automation, and robotics who is able to perform bloodless neurosurgery. As for the basic sciences, it seems likely that genetic manipulation of cells and novel concepts in immunology will make the ``magic bullet'' against cancer a reality; tumor cells with transfected genes -- cytokine genes or genes for highly immunogenic antigens -- hold promise for the treatment of cancer.
Julio Sotelo, M.D.
Copyright © 2001 Massachusetts Medical Society. All rights reserved. The New England Journal of Medicine is a registered trademark of the MMS.
"About this title" may belong to another edition of this title.
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. pp. 1080. Seller Inventory # 7631006
Quantity: 1 available
Seller: Books Puddle, Woodside, NY, U.S.A.
Condition: New. pp. 1080 2nd Edition. Seller Inventory # 26249665
Seller: books4less (Versandantiquariat Petra Gros GmbH & Co. KG), Welling, Germany
Hardcover-Großformat. Condition: Gut. 2. Ed. 1052 Seiten; Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber. Es befindet sich neben dem Rückenschild lediglich ein Bibliotheksstempel im Buch; ordnungsgemäß entwidmet. In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 3550. Seller Inventory # 2003586
Quantity: 1 available
Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEOCT25-90342
Seller: Antiquariat BehnkeBuch, Neu Kaliß, Germany
28,5*21,5 cm. OHalbleinenband. Auflage: Subsequent. 1215 Seiten Eine Ecke deutlich bestossen, sonst gut. L20-5 ISBN 9780443064265 Wichtiger Hinweis: Aufgrund der EPR-Regelung zur Zeit KEIN Versand in EU-Länder. Due to EPR, there is currently no delivery to EU-countries. Sprache: Englisch Gewicht in Gramm: 3600. Seller Inventory # 137842
Quantity: 1 available
Seller: BUCHSERVICE / ANTIQUARIAT Lars Lutzer, Wahlstedt, Germany
Condition: gut. 2001. Brain Tumors: An Encyclopedic Approach In englischer Sprache. pages. Seller Inventory # BN428918
Quantity: 1 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. pp. 1080. Seller Inventory # 18249675
Quantity: 4 available
Seller: Libro Co. Italia Srl, San Casciano Val di Pesa, FI, Italy
Rilegato in Tela. Condition: fine. English Text.Milano, 2000; clothbound, pp. 1080, cm 23x28. Libro. Seller Inventory # 3345445
Quantity: 1 available
Seller: UK BOOKS STORE, London, LONDO, United Kingdom
Condition: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability. Seller Inventory # CBS 9780443064265
Quantity: 3 available